Jeffrey Stambough, MD
Orthopaedic Surgery · Charlotte, NCNPI 1215220546
Payments from drug & device makers
Across 17 payments — averaging $406.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$4K
- Medacta USA, Inc.$2K
- Curvebeam LLC$567
- Nanovis LLC$200
- Zimmer Biomet$123
- Globus Medical$104
- plus $168 from 3 others
What the payments were for
- Consulting fees$6,03887%
- Travel & lodging$2413%
- Food & beverage$6279%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $4,227 |
| Medacta USA, Inc. | 2 | $1,517 |
| Curvebeam LLC | 2 | $567 |
| Nanovis LLC | 1 | $200 |
| Zimmer Biomet | 1 | $123 |
| Globus Medical(2 entities) | 3 | $104 |
| Johnson & Johnson | 1 | $90 |
| Sanara Medtech Inc. | 1 | $62 |
| Orthalign Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HIP7$3,271
- CORI$2,633
- GMK REVISION$1,500
- REAL INTELLIGENCE$638
- REDAPT$531
- OR3O$425
- Accelero-None$123
How this compares
$6,906 in reported general payments places this provider in the 55th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CeftriaxoneCeftriaxone Sodium | 14 | $1,491 |
| Celecoxib | 55 | $1,231 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $630 |
| Doxycycline Hyclate | 14 | $578 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 66 | $522 |
| Meloxicam | 125 | $429 |
| Gabapentin | 20 | $404 |
| Cephalexin | 20 | $314 |
| Tizanidine Hcl | 50 | $278 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $146 |
| Oxycodone Hcl | 24 | $118 |
| Mupirocin | 16 | $99 |
| Tramadol Hcl | 17 | $55 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Charlotte
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- John MasonCharlotte$6.2M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$5.2M
- Carroll JonesCharlotte$3.9M
- John MasonisCharlotte$3.9M
- Patrick ConnorCharlotte$3M
- Bruce CohenCharlotte$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.